Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. HUVR:IN
2. TAP
3. DELL
4. ROIV
5. ANET
6. NKE
7. PANW
8. CL
9. SNDK
10. SPG

Go back to Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
(NASDAQ: CMND) Delayed: 1.16 -0.54 (31.76%)
Previous Close $1.70    52 Week High $ 
Open $1.50    52 Week Low $ 
Day High $1.56    P/E N/A 
Day Low $1.16    EPS $ 
Volume 15,512,723